Hirtle Callaghan & Co’s MetLife MET Stock Holding History

Hirtle Callaghan & Co’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-4,276	Closed	-$184K	–	179
2015 Q4	$184K	Hold	4,276	–	–	0.04%	61
2015 Q3	$180K	Hold	4,276	–	–	0.03%	85
2015 Q2	$213K	Buy	+4,276	New	+$202K	0.07%	71

Other funds holding MET

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Hirtle Callaghan & Co's MET Position: Q1 2016 in Review

Hirtle Callaghan & Co sold out of MetLife (MET) in Q1 2016, closing a stake of 4,276 shares — an estimated $184K sold.

Hirtle Callaghan & Co first reported a position in MET in Q2 2015 and held it in 3 quarters. The position peaked at $213K in Q2 2015. 970 funds tracked by Wall St. Rank hold MET as of Q1 2016.

Hirtle Callaghan & Co reported no remaining MetLife position as of Q1 2016 after selling out during the quarter.
Hirtle Callaghan & Co sold 4,276 MetLife shares in Q1 2016, an estimated $184K.
Hirtle Callaghan & Co first reported a position in MetLife in Q2 2015 and held it in 3 quarters.
Hirtle Callaghan & Co's MetLife position peaked at $213K in Q2 2015.
970 funds tracked by Wall St. Rank held MetLife as of Q1 2016.

Based on Hirtle Callaghan & Co's 13F filing for Q1 2016, filed 6 May 2016.